Structure Therapeutics Inc. (GPCR) News
Track canonical SquawkNews coverage tagged to GPCR, Structure Therapeutics Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 7 indexed stories across 5 publication days and is ordered by the same first-publication timeline used by LiveCast.
M
VKTX, GPCR, ALT stocks jump after Novo Nordisk M&A signal
Novo Nordisk said it could pursue larger acquisitions while targeting more than five “multi-blockbuster” launches by 2030, lifting smaller obesity players: Viking Therapeutics gained nearly 4%, Structure Therapeutics ros
EQUITY | Sep 22, 2026, 05:29 AM UTC
L
Citizens maintains $110 per-share price target on Structure Therapeutics
Citizens maintained a $110.00-per-share price target for Structure Therapeutics.
EQUITY | Sep 09, 2026, 01:05 PM UTC
M
Structure Therapeutics posts positive early data for oral weight-loss program
Structure Therapeutics reported Phase 1/2a SAD results for ACCG-2671, an oral amylin receptor agonist, citing ~6-day half-life, no serious adverse events, and target engagement including up to 3.3% body weight loss.
EQUITY | Sep 08, 2026, 12:13 PM UTC
L
GPCR - Structure Therapeutics Reports Positive Clinical Data Across Oral Small Molecule Amylin and GLP-1 Programs for Chronic Weight Managem
GPCR - Structure Therapeutics Reports Positive Clinical Data Across Oral Small Molecule Amylin and GLP-1 Programs for Chronic Weight Management
EQUITY | Sep 08, 2026, 12:02 PM UTC
L
Structure Therapeutics to participate in upcoming healthcare investor conferences
Structure Therapeutics Inc. said management will participate in three healthcare investor conferences, as outlined in its latest announcement.
EQUITY | Sep 03, 2026, 11:38 AM UTC
L
GPCR - Structure Therapeutics to Participate in Upcoming Healthcare Investor Conferences
GPCR - Structure Therapeutics to Participate in Upcoming Healthcare Investor Conferences
EQUITY | Sep 03, 2026, 11:30 AM UTC
H
GLP-1 Drugs Disrupt Food Chain
GLP-1 medications are changing consumer behavior, reducing food consumption and increasing demand for nutrient-dense products, affecting various industries including food, pharmaceuticals, and airlines.
EQUITY | Jun 22, 2026, 11:18 AM UTC